Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invega vs Risperdal Brain Effects in Schizophrenia
NCT00937261Phase 4Unknown
- Sponsor
- University of California, Irvine
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of paliperidone in schizophrenia (2 arms), sponsored by University of California, Irvine. Primary endpoint: Comparison of BOLD signal activation and FDG metabolism of the DLPFC, superior temporal gyrus and amygdala. Status: unknown.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00937261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937261.